XOMA Royalty Corp. (XOMA)
26.92
-0.35
(-1.28%)
USD |
NASDAQ |
Jan 22, 16:00
26.75
-0.17
(-0.63%)
After-Hours: 20:00
XOMA Royalty Cash from Investing (Quarterly): 58.21M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | -2.227M |
| Recursion Pharmaceuticals, Inc. | -2.549M |
| Rezolute, Inc. | -68.49M |
| Vistagen Therapeutics, Inc. | -0.094M |
| Zevra Therapeutics, Inc. | -4.576M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.296M |
| Cash from Financing (Quarterly) | -5.849M |
| Free Cash Flow | -15.89M |
| Free Cash Flow Per Share (Quarterly) | -0.0528 |
| Free Cash Flow to Equity (Quarterly) | -18.29M |
| Free Cash Flow to Firm (Quarterly) | 2.332M |
| Free Cash Flow Yield | -3.60% |